Overview
- 35 inspections across 31 sites are on record.
- 9 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-04-23.
At a glance
Inspections
35
Sites
31
Observations
9
Career since
Jan 2017
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Sitec Labs Limited | 23 Apr 2026 | Human Drugs | On file |
| Cliantha Research Limited | 17 Apr 2026 | Human Drugs | On file |
| Frontage Laboratories Shanghai Co., Ltd. | 5 Feb 2026 | Human Drugs | |
| Labcorp Drug Development | 30 Jan 2026 | Human Drugs | |
| Amphastar Pharmaceuticals, Inc. | 7 Nov 2025 | Human Drugs | On file |
Sites inspected
Sitec Labs LimitedNavi Mumbai, India1 insp.
Cliantha Research LimitedAhmedabad, India1 insp.
Frontage Laboratories Shanghai Co., Ltd.Shanghai, China1 insp.
Labcorp Drug DevelopmentShanghai, China1 insp.
Amphastar Pharmaceuticals, Inc.Rancho Cucamonga, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Sylvestre K Dossou4 shared
Amanda Lewin4 shared
Hasan A Irier3 shared
Makini Cobourne-Duval3 shared
Joseph L Despins2 shared
Xiaohan Cai2 shared
Xingfang Li1 shared
Koffi A Amegadje1 shared
Anna M Brannen1 shared
Miguel A Martinez1 shared
Full investigator report
Get the verbatim findings behind Kara A Scheibner's 9 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site